Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204678) titled 'PMCF Study of Precise Pro Rx for Carotid Artery Disease' on Sept. 24.

Study Type: Observational

Primary Sponsor: Cordis Corporation

Condition: Carotid Artery Stenosis

Intervention: Device: PRECISE PRO Rx Nitinol Stent System

Recruitment Status: Not recruiting

Date of First Enrollment: September 30, 2025

Target Sample Size: 187

To know more, visit https://clinicaltrials.gov/study/NCT07204678

Published by HT Digital Content Services with permission from Health Daily Digest....